Västra Hamnen Market Focus: Bioextrax: Which would you like to hear first?
21 oktober, 10:30
21 oktober, 10:30
Good news and bad news caused some turbulence in the share price of Bioextrax recently. The good news is that Konkan Specialty Products is planning to produce more PHA than previously thought. The bad news is that the commercial agreement with one of the world’s three largest chemical companies is being delayed.
Read the full update here.
About Market Focus
The research report is prepared as part of Market Focus, Västra Hamnen Corporate Finance's commissioned research offering.
This is a press release from Västra Hamnen Corporate Finance AB.
Web: vhcorp.se
Twitter: @vhcorp_se (https://x.com/vhcorp_se)
21 oktober, 10:30
Good news and bad news caused some turbulence in the share price of Bioextrax recently. The good news is that Konkan Specialty Products is planning to produce more PHA than previously thought. The bad news is that the commercial agreement with one of the world’s three largest chemical companies is being delayed.
Read the full update here.
About Market Focus
The research report is prepared as part of Market Focus, Västra Hamnen Corporate Finance's commissioned research offering.
This is a press release from Västra Hamnen Corporate Finance AB.
Web: vhcorp.se
Twitter: @vhcorp_se (https://x.com/vhcorp_se)
Börsprognos
Aktieanalyser
Rapporter
Förvaltarnas investeringar
Placerapodden
Aktieanalyser
Rapporter
Förvaltarnas investeringar
Placerapodden
1 DAG %
Senast
OMX Stockholm 30
1 DAG %
Senast
2 780,58